ConductScience.org, home

Paper7600567

Pharmacokinetics, tissue distribution, and in vivo antitumor effects of the antimelanoma immunotoxin ZME-gelonin.

Mujoo K and 3 others. Cancer Immunol Immunother, 1995. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. Pharmacokinetics, tissue distribution, and in vivo antitumor effects of the antimelanoma immunotoxin ZME-gelonin. Papers, record 7600567. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7600567

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetics, tissue distribution, and in vivo antitumor effects of the antimelanoma immunotoxin ZME-gelonin.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
1995
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
0.74
iCite
Revised in PubMed
2024-04-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mujoo KK
2Cheung LL
3Murray JLJ L
4Rosenblum MGM G

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Agents, PhytogenicMajor topic
ImmunotoxinsMajor topic
MelanomaMajor topic
Plant ProteinsMajor topic
Protein Synthesis InhibitorsMajor topic
Animals
Drug Screening Assays, Antitumor
Female
Injections, Intraperitoneal
Mice
Mice, Inbred BALB C
Mice, Nude
Neoplasm Transplantation
Proteoglycans
Ribosome Inactivating Proteins, Type 1
Tissue Distribution
Transplantation, Heterologous

Source PubMed

Download CSV of topics

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17189578Tumor localization of radio-labeled antibodies against carcinoembryonic antigen in patients with carcinoma: a critical evaluation.N Engl J Med1980https://conductscience.org/library/papers/7189578PubMed
26822875Imaging of melanoma with L-131-labeled monoclonal antibodies.J Nucl Med1983https://conductscience.org/library/papers/6822875PubMed
33698030Pharmacokinetics of radiolabeled monoclonal antibody B6.2 in patients with metastatic breast cancer.Cancer Res1986https://conductscience.org/library/papers/3698030PubMed
43821916Radioimmunoimaging in malignant melanoma patients with the use of indium-111-labeled antimelanoma monoclonal antibody (ZME-018) to high-molecular-weight antigen.NCI Monogr1987https://conductscience.org/library/papers/3821916PubMed
56218613Immunotoxins: a new approach to cancer therapy.Science1983https://conductscience.org/library/papers/6218613PubMed
63930572Characterization of immunotoxins active against ovarian cancer cell lines.J Clin Invest1985https://conductscience.org/library/papers/3930572PubMed
72253201Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin.Cancer Res1990https://conductscience.org/library/papers/2253201PubMed
87391060Gelonin, a new inhibitor of protein synthesis, nontoxic to intact cells. Isolation, characterization, and preparation of cytotoxic complexes with concanavalin A.J Biol Chem1980https://conductscience.org/library/papers/7391060PubMed
93499221New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo.Cancer Res1987https://conductscience.org/library/papers/3499221PubMed
103495329Immunotoxins to a human melanoma-associated antigen: comparison of gelonin with ricin and other A chain conjugates.Cancer Res1987https://conductscience.org/library/papers/3495329PubMed
114044586Purified immunotoxins that are reactive with human lymphoid cells. Monoclonal antibodies conjugated to the ribosome-inactivating proteins gelonin and the pokeweed antiviral proteins.J Biol Chem1985https://conductscience.org/library/papers/4044586PubMed
127033148Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies.Int J Cancer1981https://conductscience.org/library/papers/7033148PubMed
132738650Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer.J Nucl Med1989https://conductscience.org/library/papers/2738650PubMed
143492271Effect of chemical deglycosylation of ricin A chain on the in vivo fate and cytotoxic activity of an immunotoxin composed of ricin A chain and anti-Thy 1.1 antibody.Cancer Res1987https://conductscience.org/library/papers/3492271PubMed
152899092In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. IV. Cytotoxic effect of an anti-T11-gelonin immunotoxin.J Clin Invest1988https://conductscience.org/library/papers/2899092PubMed
167375942Clinical radioimmunodetection of cancer with radioactive antibodies to human chorionic gonadotropin.Science1980https://conductscience.org/library/papers/7375942PubMed
172461993Ricin A-chain containing immunotoxins directed against different epitopes on the CD2 molecule differ in their ability to kill normal and malignant T cells.J Immunol1988https://conductscience.org/library/papers/2461993PubMed
183502450Effect of linkage variation on pharmacokinetics of ricin A chain-antibody conjugates in normal rats.Anticancer Drug Des1986https://conductscience.org/library/papers/3502450PubMed
193317828Redesigning nature's poisons to create anti-tumor reagents.Science1987https://conductscience.org/library/papers/3317828PubMed
203536124Immunotoxins.Cell1986https://conductscience.org/library/papers/3536124PubMed

See all 28 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
35338415Targeted Delivery of Endosomal Escape Peptides to Enhance Immunotoxin Potency and Anti-cancer Efficacy.AAPS J2022https://conductscience.org/library/papers/35338415PubMed
31293965The Melding of Drug Screening Platforms for Melanoma.Front Oncol2019https://conductscience.org/library/papers/31293965PubMed
26636901Key factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and development.MAbs2016https://conductscience.org/library/papers/26636901PubMed
25341935Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.Curr Pharm Des2014https://conductscience.org/library/papers/25341935PubMed
23973813Chemically and biologically synthesized CPP-modified gelonin for enhanced anti-tumor activity.J Control Release2013https://conductscience.org/library/papers/23973813PubMed
22190999Cell Internalization Studies of Gadofullerene-(ZME-018) Immunoconjugates into A375m Melanoma Cells.Transl Oncol2011https://conductscience.org/library/papers/22190999PubMed
16790087The antimelanoma immunocytokine scFvMEL/TNF shows reduced toxicity and potent antitumor activity against human tumor xenografts.Neoplasia2006https://conductscience.org/library/papers/16790087PubMed
16611405Targeted apoptosis activation with GrB/scFvMEL modulates melanoma growth, metastatic spread, chemosensitivity, and radiosensitivity.Neoplasia2006https://conductscience.org/library/papers/16611405PubMed
14649886Targeting the over-expressed urokinase-type plasminogen activator receptor on glioblastoma multiforme.J Neurooncol2003https://conductscience.org/library/papers/14649886PubMed
14627129Preclinical evaluation of anti-CD86 immunotoxin in rhesus monkeys: analysis of systemic toxicity, pharmacokinetics, and effect on primary T-cell responses.Cancer Immunol Immunother2003https://conductscience.org/library/papers/14627129PubMed
12952291Immunotoxin therapy for CNS tumor.J Neurooncol2003https://conductscience.org/library/papers/12952291PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7600567

GET https://conductscience.org/api/papers/v1/7600567/references?page=2